Rekah Pharmaceutical Industry Ltd. REKA.TA Stock
Rekah Pharmaceutical Industry Ltd. Price Chart
Rekah Pharmaceutical Industry Ltd. REKA.TA Financial and Trading Overview
Rekah Pharmaceutical Industry Ltd. stock price | 1400 ILA |
Previous Close | 1612 ILA |
Open | 1612 ILA |
Bid | 1697 ILA x 30000 |
Ask | 1766 ILA x 6900 |
Day's Range | 1634 - 1667 ILA |
52 Week Range | 1467 - 2162 ILA |
Volume | 330 ILA |
Avg. Volume | 3.24K ILA |
Market Cap | 190.28M ILA |
Beta (5Y Monthly) | N/A |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.61 ILA |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | April 6, 2022 |
1y Target Est | N/A |
REKA.TA Valuation Measures
Enterprise Value | 184M ILA |
Trailing P/E | N/A |
Forward P/E | N/A |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | N/A |
Price/Book (mrq) | 117.43572 |
Enterprise Value/Revenue | N/A |
Enterprise Value/EBITDA | N/A |
Trading Information
Rekah Pharmaceutical Industry Ltd. Stock Price History
Beta (5Y Monthly) | N/A |
52-Week Change | -10.42% |
S&P500 52-Week Change | 20.43% |
52 Week High | 2162 ILA |
52 Week Low | 1467 ILA |
50-Day Moving Average | 1650.86 ILA |
200-Day Moving Average | 1681.7 ILA |
REKA.TA Share Statistics
Avg. Volume (3 month) | 3.24K ILA |
Avg. Daily Volume (10-Days) | 1.16K ILA |
Shares Outstanding | 11.41M |
Float | N/A |
Short Ratio | N/A |
% Held by Insiders | 37.27% |
% Held by Institutions | 42.65% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 0 |
Trailing Annual Dividend Yield | 0% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0 |
Last Split Factor |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | March 31, 2023 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | 0% |
Operating Margin (ttm) | 0% |
Gross Margin | 0% |
EBITDA Margin | 0% |
Management Effectiveness
Return on Assets (ttm) | N/A |
Return on Equity (ttm) | N/A |
Income Statement
Revenue (ttm) | N/A |
Revenue Per Share (ttm) | 25.62 ILA |
Quarterly Revenue Growth (yoy) | N/A |
Gross Profit (ttm) | N/A |
EBITDA | N/A |
Net Income Avi to Common (ttm) | N/A |
Diluted EPS (ttm) | -0.18 |
Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
Total Cash (mrq) | N/A |
Total Cash Per Share (mrq) | N/A |
Total Debt (mrq) | N/A |
Total Debt/Equity (mrq) | N/A |
Current Ratio (mrq) | N/A |
Book Value Per Share (mrq) | 14.195 |
Cash Flow Statement
Operating Cash Flow (ttm) | N/A |
Levered Free Cash Flow (ttm) | N/A |
Profile of Rekah Pharmaceutical Industry Ltd.
Country | Israel |
State | N/A |
City | Holon |
Address | 30 Hamelach Street |
ZIP | 5881904 |
Phone | 972 3 558 1233 |
Website | https://www.rekah.co.il |
Industry | Drug Manufacturers-Specialty & Generic |
Sector(s) | Healthcare |
Full Time Employees | 399 |
Rekah Pharmaceutical Industry Ltd. engages in the manufacture, marketing, sale, and distribution of prescription and OTC drugs, dermo-cosmetics, vitamins, and nutritional supplements in Israel. The company offers steroid tablets; antibiotics, including penicillin and cephalosporin; drops and ointments to treat allergies, infections, and dryness of the eyes; baby products; and dermatological preparations. Its portfolio of products comprise approximately 280 drugs used in various medical fields. Rekah Pharmaceutical Industry Ltd. was founded in 1941 and is based in Holon, Israel.
Q&A For Rekah Pharmaceutical Industry Ltd. Stock
What is a current REKA.TA stock price?
Rekah Pharmaceutical Industry Ltd. REKA.TA stock price today per share is 1400 ILA.
How to purchase Rekah Pharmaceutical Industry Ltd. stock?
You can buy REKA.TA shares on the Tel Aviv exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Rekah Pharmaceutical Industry Ltd.?
The stock symbol or ticker of Rekah Pharmaceutical Industry Ltd. is REKA.TA.
Which industry does the Rekah Pharmaceutical Industry Ltd. company belong to?
The Rekah Pharmaceutical Industry Ltd. industry is Drug Manufacturers-Specialty & Generic.
How many shares does Rekah Pharmaceutical Industry Ltd. have in circulation?
The max supply of Rekah Pharmaceutical Industry Ltd. shares is 114.15K.
What is Rekah Pharmaceutical Industry Ltd. Price to Earnings Ratio (PE Ratio)?
Rekah Pharmaceutical Industry Ltd. PE Ratio is now.
What was Rekah Pharmaceutical Industry Ltd. earnings per share over the trailing 12 months (TTM)?
Rekah Pharmaceutical Industry Ltd. EPS is -0.61 ILA over the trailing 12 months.
Which sector does the Rekah Pharmaceutical Industry Ltd. company belong to?
The Rekah Pharmaceutical Industry Ltd. sector is Healthcare.